Unravelling the rate of action of hits in the Leishmania donovani box using standard drugs amphotericin B and miltefosine.
In recent years, the neglected diseases drug discovery community has elected phenotypic screening as the key approach for the identification of novel hit compounds. However, when this approach is applied, important questions related to the mode of action for these compounds remain unanswered. One of...
Furkejuvvon:
Váldodahkkit: | Diana Tegazzini (Dahkki), Juan Cantizani (Dahkki), Imanol Peña (Dahkki), Julio Martín (Dahkki), Jose M Coterón (Dahkki) |
---|---|
Materiálatiipa: | Girji |
Almmustuhtton: |
Public Library of Science (PLoS),
2017-05-01T00:00:00Z.
|
Fáttát: | |
Liŋkkat: | Connect to this object online. |
Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Geahča maid
-
Elucidating the possible mechanism of action of some pathogen box compounds against Leishmania donovani.
Dahkki: Wandayi Emmanuel Amlabu, et al.
Almmustuhtton: (2020) -
Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis.
Dahkki: Andrew A Voak, et al.
Almmustuhtton: (2021) -
Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress.
Dahkki: Deepak Kumar Deep, et al.
Almmustuhtton: (2017) -
Leishmania donovani Growth Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture
Dahkki: Tadele M, et al.
Almmustuhtton: (2020) -
In vitro activity and mode of action of phenolic compounds on Leishmania donovani.
Dahkki: Christine Achiaa Antwi, et al.
Almmustuhtton: (2019)